Area of research
Surgery · Pulmonary and Respiratory Medicine
Research interest
Research focused on Renal cell carcinoma and Nephrectomy, with related work in Guideline, Surgical oncology, KRAS. Notable publications include 'Incidence and long-term prognosis of papillary compared to clear cell renal cell carcinoma – A multicentre study', 'Validation of CRP as prognostic marker for renal cell carcinoma in a large series of patients', and 'Targeting of KRAS mutant tumors by HSP90 inhibitors involves degradation of STK33'.
Management of Germ Cell Tumours of the Testis in Adult Patients. German Clinical Practice Guideline Part I: Epidemiology, Classification, Diagnosis, Prognosis, Fertility Preservation, and Treatment Recommendations for Localized Stages
Management of Germ Cell Tumours of the Testes in Adult Patients: German Clinical Practice Guideline, PART II – Recommendations for the Treatment of Advanced, Recurrent, and Refractory Disease and Extragonadal and Sex Cord/Stromal Tumours and for the Management of Follow-Up, Toxicity, Quality of Life, Palliative Care, and Supportive Therapy
Animacroxam, a Novel Dual-Mode Compound Targeting Histone Deacetylases and Cytoskeletal Integrity of Testicular Germ Cell Cancer Cells
Survival advantage of partial over radical nephrectomy in patients presenting with localized renal cell carcinoma
German second-opinion network for testicular cancer: Sealing the leaky pipe between evidence and clinical practice
Clinical behavior of chromophobe renal cell carcinoma is less aggressive than that of clear cell renal cell carcinoma, independent of Fuhrman grade or tumor size
The Fuhrman grading system has no prognostic value in patients with nonsarcomatoid chromophobe renal cell carcinoma
High CRP values predict poor survival in patients with penile cancer
Small renal cell carcinomas – How dangerous are they really? Results of a large multicenter study
Interdisciplinary decision making in prostate cancer therapy – 5-years’ time trends at the Interdisciplinary Prostate Cancer Center (IPC) of the Charité Berlin
Incidence and long-term prognosis of papillary compared to clear cell renal cell carcinoma – A multicentre study
Validation of CRP as prognostic marker for renal cell carcinoma in a large series of patients
Targeting of KRAS mutant tumors by HSP90 inhibitors involves degradation of STK33
Abstract 2773: HSP90 inhibitors target KRAS mutant human tumors through degradation of STK33